Prognostic factors in intraoral squamous cell carcinoma: The influence of histologic grade

被引:215
作者
Kademani, D
Bell, RB
Bagheri, S
Holmgren, E
机构
[1] Mayo Clin, Dept Oral & Maxillofacial Surg, Rochester, MN 55905 USA
[2] Oregon Hlth Sci Univ, Portland, OR 97201 USA
[3] Legacy Emanuel Hosp & Hlth Ctr, Portland, OR 97201 USA
[4] Emory Univ, Atlanta, GA 30322 USA
关键词
D O I
10.1016/j.joms.2005.07.011
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: The purpose of this retrospective study was to review the outcome of patients with oral cavity squamous cell carcinoma treated at a single institution by primary surgical resection with or without adjuvant radiotherapy or chemoradiotherapy and to identify factors affecting survival and locoregional control. Patients and Methods: The records of 233 patients with oral cavity squamous cell carcinoma treated at a single institution from 1993 to 2003 were identified from the Legacy Emanuel Hospital and Health Center's cancer registry (Portland, OR). All patients undergoing surgical resection as a primary treatment modality were included in the stud),. Patients with nonresectable disease, distant metastasis, and those with inadequate follow-up data were excluded from the study. Patients with positive surgical margins, high-grade histology, aggressive biologic behavior, or advanced staged disease underwent adjuvant radiotherapy or chemoradiotherapy. The data collected included age, gender, race, tumor site, margin status, grade, TNM stage, cancer therapies, and cancer status. Data were statistically analyzed in an attempt to identify predictors of locoregional control and disease-free survival. Descriptive statistics were calculated for each variable and survival was calculated using the Kaplan-Meier method. Prognostic factors were analyzed using the Cox proportional hazard model. Results: Two hundred fifteen patients consisting of 1.19 men (55%) and 123 females (52%), with an average age at diagnosis of 66 years (SD +/- 14), met the criteria for inclusion in the Stud),. Average tumor size was 23.5 mm (SD +/- 14.1). Overall 5-year survival was 56% and disease-free survival at 5 years was 58%. Stage and grade were identified as having a statistically significant effect on survival (P =.014; likelihood ratio chi-square = 10.7, 3 degrees of freedom; and P =.026; likelihood ratio chi-square = 5, 1 degree of freedom, respectively). Neither age, gender, race, tumor site, nor positive margins showed 7 a statistically significant effect on Survival (P >.05). Conclusion: This Study highlights the importance of grade and stage as independent factors in predicting survival in patients with oral squamous cell carcinoma. (c) 2005 American Association of Oral and Maxillofacial Surgeons.
引用
收藏
页码:1599 / 1605
页数:7
相关论文
共 22 条
[1]  
ANNEROTH G, 1987, SCAND J DENT RES, V95, P229
[2]   Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer [J].
Bernier, J ;
Domenge, C ;
Ozsahin, M ;
Matuszewska, K ;
Lefèbvre, JL ;
Greiner, RH ;
Giralt, J ;
Maingon, P ;
Rolland, F ;
Bolla, M ;
Cognetti, F ;
Bourhis, J ;
Kirkpatrick, A ;
van Glabbeke, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1945-1952
[3]  
*CDC, 1990, JAMA-J AM MED ASSOC, V264, P678
[4]   Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck [J].
Cooper, JS ;
Pajak, TF ;
Forastiere, AA ;
Jacobs, J ;
Campbell, BH ;
Saxman, SB ;
Kish, JA ;
Kim, HE ;
Cmelak, AJ ;
Rotman, M ;
Machtay, M ;
Ensley, JF ;
Chao, KSC ;
Schultz, CJ ;
Lee, N ;
Fu, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1937-1944
[5]   PROGNOSTIC-SIGNIFICANCE OF LYMPHATIC SPREAD IN HEAD AND NECK CARCINOMAS - THERAPEUTIC IMPLICATIONS [J].
GRANDI, C ;
ALLOISIO, M ;
MOGLIA, D ;
PODRECCA, S ;
SALA, L ;
SALVATORI, P ;
MOLINARI, R .
HEAD & NECK SURGERY, 1985, 8 (02) :67-73
[6]  
Johnson N W, 1991, Int Dent J, V41, P365
[7]  
LEEMANS CR, 1994, CANCER-AM CANCER SOC, V73, P187, DOI 10.1002/1097-0142(19940101)73:1<187::AID-CNCR2820730132>3.0.CO
[8]  
2-J
[9]  
LINDBERG R, 1972, CANCER, V29, P1446, DOI 10.1002/1097-0142(197206)29:6<1446::AID-CNCR2820290604>3.0.CO
[10]  
2-C